Helix BioPharma Corp. (HBP.TO) - Stock Prices, Stock Peers & Analysis

Home
HBP.TO

Company Name	Helix BioPharma Corp.
Symbol	HBP.TO
Currency	CAD
Price	1.23
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	60,296,445
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.75 - 1.35
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Jacek Antas
Website	https://www.helixbiopharma.com

An error occurred while fetching data.

About Helix BioPharma Corp.

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and